FNCH
FINCH THERAPEUTCS GRP INC by Finch Therapeutics Group, Inc. (FNCH)
$20
About FINCH THERAPEUTCS GRP INC by Finch Therapeutics Group, Inc. (FNCH)
Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Boston, MA.
Details
Daily high
$14.20
Daily low
$13.50
Price at open
$13.50
52 Week High
$16.10
52 Week Low
$10.15
Market cap
22.8M
Dividend yield
0.00%
Volume
4,971
Avg. volume
8,333
P/E ratio
-1.61
FINCH THERAPEUTCS GRP INC by Finch Therapeutics Group, Inc. News
Details
Daily high
$14.20
Daily low
$13.50
Price at open
$13.50
52 Week High
$16.10
52 Week Low
$10.15
Market cap
22.8M
Dividend yield
0.00%
Volume
4,971
Avg. volume
8,333
P/E ratio
-1.61